Literature DB >> 29113839

Addressing Financial Toxicity: The Role of the Urologist.

Matthew Mossanen1, Angela B Smith2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29113839     DOI： 10.1016/j.juro.2017.10.039

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country.

Authors:  Chuo Yew Ting; Guan Chou Teh; Kong Leong Yu; Haridah Alias; Hui Meng Tan; Li Ping Wong
Journal:  Support Care Cancer       Date:  2019-07-10       Impact factor: 3.603

Review 2.  Financial toxicity associated with treatment of localized prostate cancer.

Authors:  Brandon S Imber; Melissa Varghese; Behfar Ehdaie; Daniel Gorovets
Journal:  Nat Rev Urol       Date:  2019-12-02       Impact factor: 14.432

3.  Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.

Authors:  Tamir N Sholklapper; Michael L Creswell; Alexandra T Payne; Michael Markel; Abigail Pepin; Michael Carrasquilla; Alan Zwart; Malika Danner; Marilyn Ayoob; Thomas Yung; Brian Collins; Deepak Kumar; Nima Aghdam; Simeng Suy; Ryan A Hankins; Keith Kowalczyk; Sean P Collins
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

4.  Treatment of complex urethral stenosis in public centers from developing countries in 21st century.

Authors:  Dane E Klett; Manaf Alom; Kevin Wymer; Aaron Potretzke
Journal:  Int Braz J Urol       Date:  2022 Mar-Apr       Impact factor: 3.050

5.  Cost talk: protocol for a stepped-wedge cluster randomized trial of an intervention helping patients and urologic surgeons discuss costs of care for slow-growing prostate cancer during shared decision-making.

Authors:  Mary C Politi; Rachel C Forcino; Katelyn Parrish; Marie-Anne Durand; A James O'Malley; Glyn Elwyn
Journal:  Trials       Date:  2021-06-29       Impact factor: 2.279

6.  Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective.

Authors:  Luciana Saboya Brito Dal Col; Danilo L Andrade; Lucas M Gon; Diego M Capibaribe; Marcelo P Amaro; Natássia C C Truzzi; Barbara R Malkomes; Leonardo O Reis
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.